Clinical Characteristics and Outcomes of Vaccinated VS Non-Vaccinated Critically Ill COVID-19 Patients: Retrospective Observation Study

References

• Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733. doi:10.1056/NEJMoa2001017
   PubMed Web of Science ®Google Scholar
• Coronavirus disease (COVID-19) pandemic; 2021. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed March 25, 2020.
   Google Scholar
• Coronavirus disease 2019 (COVID-19): situation summary; 2021. Available from: https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/summary.html. Accessed March 25, 2020.
   Google Scholar
• World Health Organization. Weekly epidemiological update—15 May 2022; 2022.
   Google Scholar
• Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383:2603–2615. doi:10.1056/NEJMoa2034577
   PubMed Web of Science ®Google Scholar
• Sadoff J, Le Gars M, Shukarev G, et al. Interim results of a Phase 1–2a Trial of Ad26.COV2. S Covid-19 vaccine. N Engl J Med. 2021;384(19):1824–1835. doi:10.1056/NEJMoa2034201
   PubMed Web of Science ®Google Scholar
• Dagan N, Barda N, Kepten E, et al. BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting. N Engl J Med. 2021;384:1412e23. doi:10.1056/NEJMoa2101765
   Google Scholar
• Tenforde MW, Olson SM, Self WH, et al. Effectiveness of Pfizer-BioNTech and moderna vaccines against COVID-19 among hospitalized adults aged 65 years in United States, January - March 2021. MMWR Morb Mortal Wkly Rep. 2021;70(18):674–679. doi:10.15585/mmwr.mm7018e1
   PubMed Web of Science ®Google Scholar
• Vasileiou E, Simpson CR, Shi T, et al. Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study. Lancet. 2021;397:1646e57. doi:10.1016/S0140-6736(21)00677-2
   Web of Science ®Google Scholar
• Bernal JL, Andrews N, Gower C, et al. Early effectiveness of COVID-19 vaccination with BNT162b2 mRNA vaccine and ChAdOx1 adenovirus vector vaccine on symptomatic disease, hospitalizations, and mortality in older adults in England. MedRxiv. 2021. doi:10.1101/2021.03.01.21252652
   Google Scholar
• Ministry of Health. COVID-19 dashboard 2021. Available from: https://covid19.moh.gov.sa. Accessed May 23, 2023.
   Google Scholar
• Brosh-Nissimov T, Orenbuch-Harroch E, Chowers M, et al. BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel. Clin Microbiol Infect. 2021;27(11):1652–1657. doi:10.1016/j.cmi.2021.06.036
   PubMed Web of Science ®Google Scholar
• Public Health Authority. Laboratory diagnosis. Available from: https://covid19.cdc.gov.sa/professionals-health-workers/laboratorydiagnosis/. Accessed December 9, 2021.
   Google Scholar
• Saudi Center for Disease Prevention and Control (Weqaya). Laboratory diagnosis of COVID-19 in suspected cases. Available from: https://covid19.cdc.gov.sa/professionals-health-workers/laboratory-diagnosis/. Accessed October 12, 2020.
   Google Scholar
• Walsh EE, Frenck RW, Falsey AR, et al. Safety and Immunogenicity of Two RNA-Based Covid-19 vaccine candidates. N Engl J Med. 2020;383(25):2439–2450. doi:10.1056/NEJMoa2027906
   PubMed Web of Science ®Google Scholar
• Barrett JR, Belij-Rammerstorfer S, Dold C, et al. Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses. Nat Med. 2021;27(2):279–288. doi:10.1038/s41591-020-01179-4
   PubMed Web of Science ®Google Scholar
• Anderson EJ, Rouphael NG, Widge AT, et al. Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults. N Engl J Med. 2020;383(25):2427–2438. doi:10.1056/NEJMoa2028436
   PubMed Web of Science ®Google Scholar
• Myers LC, Parodi SM, Escobar GJ, Liu VX. Characteristics of hospitalized adults with COVID-19 in an integrated health care system in California. JAMA. 2020;323(21):2195–2198. doi:10.1001/jama.2020.7202
   PubMed Web of Science ®Google Scholar
• Petrilli CM, Jones SA, Yang J, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020;369:m1966. doi:10.1136/bmj.m1966
   PubMed Web of Science ®Google Scholar
• Choi B, Choudhary MC, Regan J, et al. Persistence and evolution of SARS-CoV-2 in an immunocompromised host. N Engl J Med. 2020;383(23):2291–2293. doi:10.1056/NEJMc2031364
   PubMed Web of Science ®Google Scholar
• Akalin E, Azzi Y, Bartash R, et al. Covid-19 and Kidney Transplantation. N Engl J Med. 2020;382(25):2475–2477. doi:10.1056/NEJMc2011117
   PubMedGoogle Scholar
• Reischig T, Kacer M, Vlas T, et al. Insufficient response to mRNA SARS-CoV-2 vaccine and high incidence of severe COVID-19 in kidney transplant recipients during pandemic. Am J Transplant. 2022;22(3):801–812. doi:10.1111/ajt.16902
   PubMed Web of Science ®Google Scholar
• Thompson MG, Stenehjem E, Grannis S, et al. Effectiveness of Covid-19 vaccines in ambulatory and inpatient care settings. N Engl J Med. 2021;385(15):1355–1371. doi:10.1056/NEJMoa2110362
   PubMed Web of Science ®Google Scholar
• Tenforde MW, Self WH, Gaglani M, et al. Effectiveness of mRNA vaccination in preventing COVID-19-associated invasive mechanical ventilation and death - United States, March 2021-January 2022. MMWR Morb Mortal Wkly Rep. 2022;71(12):459–465. doi:10.15585/mmwr.mm7112e1
   PubMed Web of Science ®Google Scholar
• Huang I, Pranata R, Lim MA, Oehadian A, Alisjahbana B. C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis. Ther Adv Respir Dis. 2020;14:1753466620937175. doi:10.1177/1753466620937175
   Web of Science ®Google Scholar
• Pan F, Yang L, Li Y, et al. Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control study. Int J Med Sci. 2020;17(9):1281–1292. doi:10.7150/ijms.46614
   PubMed Web of Science ®Google Scholar
• Poggiali E, Zaino D, Immovilli P, et al. Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients. Clin Chim Acta. 2020;509:135–138. doi:10.1016/j.cca.2020.06.012
   PubMed Web of Science ®Google Scholar
• Lopez Bernal J, Andrews N, Gower C, et al. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study. BMJ. 2021;373:n1088. doi:10.1136/bmj.n1088
   PubMed Web of Science ®Google Scholar